Posted by MarketBeat News on Mar 5th, 2024
Immunocore (NASDAQ:IMCR – Get Free Report) had its price target hoisted by equities researchers at Mizuho from $86.00 to $90.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “buy”...
More of this article »